Cite
HARVARD Citation
Shah, A. et al. (2018). BAY 94‐9027, a PEGylated recombinant factor VIII, exhibits a prolonged half‐life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies. Haemophilia. 24 (5), pp. 733-740. [Online].